Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer
Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer
Irinotecan And Carboplatin Improve Response In NSCLC
Enzastaurin Shows Activity In Recurrent High-Grade Glioma
Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer
Gemcitabine Improves DFS In Resected Pancreatic Cancer
Rosenberg: Immunotherapy May Have Broad Potential
NCI-Approved Clinical Trials
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence